Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Urology|May 23, 2020
Gender Bias in Medicine: Does It Exist at AUA Plenary Sessions?Meenakshi Davuluri, Emily Barry, Stacy Loeb, et al.Rhode Island Medical Journal (2013)|November 28, 2023
Renal Imaging in Stone Disease: Which Modality to Choose?Iha Kaul, Sarah Moore, Emily Barry, et al.BMC Surgery|March 7, 2021
Methodology for triage of urologic surgical cases in the setting of a pandemicAhmed Aboumohamed, Josh Gottlieb, Matthew DeMasi, et al.Journal of Endourology|April 2, 2019
Does Glomerular Filtration Rate at Discharge After Partial Nephrectomy Predict Long-Term Glomerular Filtration Rate Stability?Ari Bernstein, Emily Barry, Ethan B Fram, et al.Urology Practice|May 21, 2021
OUTCOMES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN IN A MULTIRACIAL COHORT WITH NON-MUSCLE-INVASIVE BLADDER CANCEREmily Barry, Ilir Agalliu, Richard Maiman, et al.Clinical Genitourinary Cancer|June 12, 2021
Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder CancerJoseph I Kim, Denzel Zhu, Emily Barry, et al.Urologic Oncology|September 2, 2019
An evaluation of monthly maintenance therapy among patients receiving intravesical combination gemcitabine/docetaxel for nonmuscle-invasive bladder cancerMarcus J Daniels, Emily Barry, Niv Milbar, et al.Clinical Genitourinary Cancer|January 9, 2023
Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder CancerNathan Feiertag, Emily Barry, Max Abramson, et al.Urologic Oncology|July 1, 2019
Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancerMarcus J Daniels, Emily Barry, Mark Schoenberg, et al.Mabs|February 14, 2023
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-lifeEmma Davé, Oliver Durrant, Neha Dhami, et al.Pageof 2